BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

TLSA upcoming catalysts

Tiziana Life Sciences LTD: 0 upcoming industry Phase 2/3 trial readout(s) in the next 90 days (0 Phase 3), 0 upcoming FDA decision event(s), and in the last 12 months 2 readout(s) and 0 FDA event(s). Subscribe to TLSA (.ics).

Upcoming FDA decision events

DateEventStatusCompanyDrugSource
No upcoming PDUFA date or AdCom found.

Upcoming trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
No trials in this window.

FDA decision events, last 12 months

DateEventStatusCompanyDrugSource
No FDA decision events in this window.

Trial readouts, last 12 months

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-09-17P2Tiziana Life Sciences LTD TLSANCT06292923 A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis PatientsSecondary Progressive Multiple Sclerosiscompleted54
2026-04-30 est.P2Tiziana Life Sciences LTD TLSANCT06890923 Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple SclerosisNon-Active Secondary Progressive Multiple Sclerosisrecruiting55

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.